Genetics, Research and the Public Health The Case for Public Health Genetics Dr Ron Zimmern MA, FRCP - PowerPoint PPT Presentation

1 / 48
About This Presentation
Title:

Genetics, Research and the Public Health The Case for Public Health Genetics Dr Ron Zimmern MA, FRCP

Description:

Framework for the Integration of Genetic Science into Health Services ... Genetic Endowment. Natural Environment. Structural Environment. Individual Behaviour ... – PowerPoint PPT presentation

Number of Views:197
Avg rating:3.0/5.0
Slides: 49
Provided by: rdfor
Category:

less

Transcript and Presenter's Notes

Title: Genetics, Research and the Public Health The Case for Public Health Genetics Dr Ron Zimmern MA, FRCP


1
Genetics, Research and the Public HealthThe Case
for Public Health GeneticsDr Ron Zimmern MA,
FRCP, FFPHMDirector, Public Health Genetics
Unit, Cambridge
  • NHS R D Forum, Keele University
  • 12 July 2004

2
Structure of Talk
  • Public health genetics
  • Concepts in public health genetics
  • Competencies and the knowledge base
  • The research agenda in public health genetics
  • Policy considerations

3
Definitions
  • Public Health
  • The art and science of promoting health and
    preventing disease through the organised efforts
    of society
  • Public Health Genetics
  • The application of advances in genetics and
    molecular biology on promoting health and
    preventing disease

4
Framework for the Integration of Genetic Science
into Health Services
KnowledgeBase
Genetic Testing HTA and HSR Regulation and QA
Analysis Assessment
Epidemiology Policy Analysis
Building Infrastructure for the Decades Ahead
Practice
Research
Clinical, laboratory and public health practice
5
Analysis and Assessment
  • 1. Human genome epidemiology
  • The systematic application of epidemiological
    methods and approaches in population based
    studies of the impact of human genetic variation
    on health and disease
  • prevalence of genotype
  • measures of effect relative risk, absolute
    risk, population attributable fraction
  • gene-gene and gene-environment interaction
  • Policy analysis
  • science, commercial, information, educational,
    financial
  • public involvement
  • ELSI implications

6
Action and Policy Development
  • Development of health service capacity to
    integrate genomics into health care and building
    infrastructure
  • manpower planning
  • education and training
  • research and development
  • partnerships and interdisciplinarity
  • working with the commercial sector

7
Evaluation and Assurance
I. Health Technology Assessment
The ACCE Framework for genetic test evaluation
  • Two specific technical problems
  • Distinction between diagnostic tests, and
    predictive and susceptibility tests
  • Clinical validity and the population context
  • A nalytical validity
  • C linical validity
  • C linical utility
  • E thical, legal and social
  • Health Services Research
  • Effectiveness and cost-effectiveness of service
    delivery

8
Regulatory Issues
  • Three Levels
  • Statutory
  • legislation
  • regulation
  • codes of practice
  • Resource Allocation
  • NICE and HTA
  • commissioners
  • Clinical
  • governance
  • education
  • Issues in Regulation
  • Regulation of laboratories and regulation of
    tests
  • Regulation of products and regulation of service
  • Genetic tests
  • How are they to be defined?
  • Are they special and should they be regulated in
    a different manner?
  • Simple tests and complex tests?
  • 4. Regulation of over the counter tests and
    regulation of professionally ordered tests
  • 5. In house tests and tests placed on the
    market
  • 6. Adquacy of existing regulations
  • The EU Directive
  • Consumer legislation and regulation

9
Concepts in Public Health Genetics
10
Genetics
  • 1. Genetics as inheritence
  • single gene disorders inherited in a mendelian
    fashion
  • genetic services
  • familial association
  • 2. Genetics as cell and molecular biology
  • the genetic component of all human traits and
    diseases
  • the basis of development
  • modern biology

11
Determinants of Health
Genetic
Genetic Endowment
Biological
Physical
Natural Environment
Political
Social
Structural Environment
Behavioural
Individual Behaviour
12
Gene-Environment Interrelationship
13
Population and High Risk Approaches
Shift of population distribution
Geoffrey Rose Complementary approaches
90 100 110 120
130 140 150 160 170 180
Systolic B/P
14
Inherited and Complex Diseases
  • Inherited diseases
  • Cystic fibrosis Duchenne muscular dystrophy
  • Huntingtons disease Familial polyposis coli
  • Familial hypercholesterolaemia Phenylketonuria
  • Complex diseases
  • Diabetes Cardiovascular
  • Cancer Alzheimers
  • Hypertension Schizophrenia
  • Rheumatoid arthritis Learning disability

15
Penetrance
Gene (Genotype)
Other Genes
Environment
Genetic Risk
Gene-gene interaction
Gene-environment interaction
Disease Risk
Disease (Phenotype)
16
Development of Disease
0 10 20 30 40 50 60 70 80 90
Environmental Factors
Latent Period
Induction Period
Genetic Component
Death
Clinical Onset
Idea from Khoury and Cohen (1988) J Clin Epid 41,
1181
17
Gene-environment Interaction
Heart disease
PKU
Schizophrenia
Cancer
Motor vehicle accident
Cystic fibrosis
Multiple sclerosis
Alzheimers
Diabetes
Fragile X
Asthma
TB
Duchenne muscular dystrophy
Struck by lightning
Obesity
Rheumatoid arthritis
Meningococcus
Autism
Totally Genetic
Totally Environmental
18
Risk, Genes, and Environment
Environmental Exposure TOTAL RR 2.0
Prev95 RR1.05
19
Complexity in Genetic Science
  • Gene-gene interaction
  • Control of transcription
  • Alternative splicing
  • Post translational modification
  • Temporal effects

20
Genetic Exceptionalism
  • Genetic exceptionalism is the claim that genetic
    information is sufficiently different from other
    types of health information that it deserves
    special protection or other exceptional measures

21
Genetic Exceptionalism
Arguments For
Arguments against
  • 1. Concern about genetic prophecy - can predict
    our medical future
  • 2. Concern for kin- relevant to other family
    members
  • 3. Concern for discrimination -
    stigmatisation
  • 4. Concern for identification- unique nature
    and stability of DNA

Adapted from TH Murray Genetic Exceptionalism
and Future Diaries (1997)
22
The Impact of Genetics
A better understanding of disease mechanisms
A new categorisation of disease based on genotype
Greater diagnostic potential through genetic
testing
A faster and more rational drug discovery process
Novel therapeutic interventions and
pharmaco- genetics
Opportunities for the prediction and prevention
of disease
23
Susceptibility Testing and Prevention
  • 1. Genotype-phenotyope correlation
  • 2. Public acceptability
  • 3. Effective interventions
  • 4. Behaviour and compliance
  • Societal implications - justice and
    discrimination

24
Competencies and the Knowledge Base
25
Genetic Literacy and Society
  • Specialists in public health genetics
  • Health professionals and health service managers
  • Media
  • Commercial, legal and financial community
  • Policy makers
  • Politicians
  • Patients
  • General public

26
Professonal Competence
THE SCIENCE
PROFESSIONAL COMPETENCE IN PUBLIC HEALTH GENETICS
Interpersonal Skills
Personal Development
THE ART
Political Sensitivity Ethnicity Cultural
differences
27
Knowledge Base for Public Health Genetics
  • GENETIC SCIENCE
  • Basic concepts of mendelian genetics
  • Family histories and pedigrees
  • Risk assessment and communication
  • Principles of genetic epidemiology
  • Principles of molecular genetics
  • Genetic testing and screening
  • Genetics of common disorders
  • Gene-environment interaction

28
Proposals for Public Health Genetics in UK
  • Establish a sub-specialty of public health
    genetics
  • Establish competencies and training programme
  • Establish 12 posts in the UK over next 5 to 6
    years
  • 9 in England 1 in Wales 1 in Scotland and 1 in
    N. Ireland
  • Establish links with NHS R D agenda and
    specialised commissioning
  • Establish an understanding of the commercial
    sector and its relevance for public health

29
Education in Genetics for Health Professionals
  • Strategy for increasing the knowledge and
    understanding of genetics across the health care
    professions
  • physicians, nurses, pharmacists, dieticians,
    public health professionals, health service
    managers
  • Commitment of Wellcome Trust to background report
  • Strategy commissioned jointly by Wellcome Trust
    and DH
  • Wide involvement of professional and public
    stakeholders

30
Addressing Genetics, Delivering Health
  • Main Findings
  • Importance of genetics accepted but most
    practitioners are still at the stage of
    unconscious incompetence
  • Genetics is worthy of a special initiative
  • Developing genetics education will be a huge
    undertaking, unprecedented in its scale and
    complexity
  • Main Recommendations
  • There should be a National Steering Group to
    ensure strategic leadership and commitment
  • There should be an Education Centre to provide
    focus, coordination and energy to the work
  • A major programme should be established to raise
    awareness, develop genetics in formal and
    informal curriculum and educate by support to
    clinical practice
  • Substantial resources will be required
    2-3million pa simply to provide a supporting
    infrastructure


31
The Research Agenda in Public Health Genetics
Epidemiology, Health Technology Assessment,
Health Services Research Ethical, Legal and
Social Research
32
Epidemiological Research
  • DNA banks
  • population based
  • disease based
  • Primary research
  • linkage studies
  • genetic association studies
  • gene-environment interaction
  • Secondary research
  • systematic reviews
  • meta-analysis

A stored collection of genetic samples, in the
form of blood or tissue, that can be linked with
medical and geanological or lifestyle information
from a specific population, gathered using a
process of generalised consent. Austin et al
(2003) UK BioBank, DeCode (Iceland), Estonia,
Latvia, CartaGene (Canada)
Methodology for appraising association studies
Meta-analysis of lipoprotein lipase and heart
disease Meta-analysis of CYP2D9 and
Warfarin Estimates of family history risk in
common conditions
33
?32 heterozygotes partly protected from infection
and show slower disease progression to AIDS
Chasman DI et al. (2004) JAMA 291, 2821-2827
34
Metabolic Gene Variants and Cigarette Smoking
Smokers showed the greatest reduction in birth
weight (av.1285g) Non-smokers with same
genotype showed no decrease in birth weight
Adverse effects of smoking modified by maternal
genotype
Wang X et al. (2002). JAMA. 287, 195-202
35
van de Vijver MJ (2002). N Engl J Med. 347,
1999-2009
36
Research Activities in the PHGU (1)
  • Health Technology Assessment
  • Use of molecular genetic testing in FH
  • Evaluating the ACCE methodology for genetic tests
  • Gene expression arrays and cancer
  • 2. Health Service Research
  • Pathways of care in the genetic testing of
    childhood learning disability
  • Establishment of a database for health economic
    studies in genetic services
  • Nutrigenomics

37
Research Activities in the PHGU (2)
  • 3. ELSI Research
  • IPR and DNA patents
  • Regulatory bodies for genetic technologies
  • Legal aspects of stem cell research
  • Governance of medical databases
  • Genetic research in ICUs capacity and consent
  • The law and human tissue
  • Causation in epidemiological research
  • Conceptual analysis of disease with special
    reference to genetics
  • Regulation, information and genetics

38
  • Policy Considerations

39
A Framework The Nuffield Genetics Scenario
Project
Two drivers 1. Science and its capacity to
improve human health 2. Public attitudes towards
genetics
External Drivers
Public attitudes
Science
Political and policy machine
The regulatory framework
  • Six policy issues
  • 1. The regulatory framework
  • 2. Educational strategies
  • 3. The science base
  • 4. Commercial considerations
  • 5. Information and confidentiality
  • 6. Financial framework for health

Educational strategies
Commercial
Info and confidentiality
Financial Framework
Heatlth Services
Ethical, legal social
40
Science and Its Capacity to Improve Human Health
Science and its capacity to improve human health
Pace at which genetic science will impact on
health and health services uncertain
  • Is the science too complex? Will it be too
    expensive?
  • Can it deliver?
  • economic constraints
  • scientific constraints

Pace - optimists and realists
41
Public Attitudes Towards Genetics
  • Widespread misunderstanding about genetics
  • genetic determinism
  • genetic risk

Public attitudes towards genetics
Role of media and of scientists Legacy of
eugenics Public disquiet about genetic
discrimination
42
YES
OPTIMUM SITUATION
PUBLIC ACCEPT
NO
-
YES
SCIENCE DELIVERS
NO
43
YES
Basic science progresses No proven clinical
benefit
Public eager and accept but science cannot deliver
PUBLIC ACCEPTS
NO
YES
NO
SCIENCE DELIVERS
44
YES
Stage II Public acceptance declines due to
failure of science to provide benefits
PUBLIC ACCEPTS
NO
YES
SCIENCE DELIVERS
NO
45
YES
PUBLIC ACCEPTS
Science delivers but public do not accept
Luddite views Stop advances in knowledge
NO
YES
SCIENCE DELIVERS
NO
46
YES
PUBLIC ACCEPTS
Stage II Continued demonization of science
destroys science base
NO
NO
SCIENCE DELIVERS
YES
47
Conclusion
  • Genetic factors are important determinants of
    health and disease in human populations
  • Genes are not (in most instances) deterministic
    of disease, interacting as they do with each
    other and with environmental factors
  • Genetic exceptionalism should be resisted
  • Genetic science and its impact on health is ill
    understood and steps should be taken to improve
    genetic literacy among health professionals and
    across society as a whole
  • Genetic factors should be taken into account in
    epidemiological studies
  • Those involved in HSR and HTA should develop an
    understanding of genetic science in view of its
    growing impact on health service provision
  • Public health genetics should be developed as an
    essential element of the public health workforce
  • The impact of genetics on society will depend as
    much on public acceptance as on scientific
    developments
  • The application of genetics to benefit human
    health will be determined as much by geenral
    policy considerations (science, commerce,
    regulation) as to specific changes in service
    provision within the NHS

48
www.cgkp.org.uk www.phgu.org.uk
www.cmgp.org.uk
Write a Comment
User Comments (0)
About PowerShow.com